Virologic suppression, defined as HIV-1 RNA at less than 200 copies/mL Measured at Week 48 [clinicaltrials_resource:b314aa1ff48639f4bd8dc7e93f9a3f0c]
Participants will receive enhanced nursing telephone support plus care as usual.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Virologic suppression, defined as HIV-1 RNA at less than 200 copies/mL Measured at Week 48 [clinicaltrials_resource:b314aa1ff48639f4bd8dc7e93f9a3f0c]
Participants will receive enhanced nursing telephone support plus care as usual.
Bio2RDF identifier
b314aa1ff48639f4bd8dc7e93f9a3f0c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b314aa1ff48639f4bd8dc7e93f9a3f0c
measure [clinicaltrials_vocabulary:measure]
Virologic suppression, defined as HIV-1 RNA at less than 200 copies/mL
time frame [clinicaltrials_vocabulary:time-frame]
Measured at Week 48
description
Participants will receive enhanced nursing telephone support plus care as usual.
identifier
clinicaltrials_resource:b314aa1ff48639f4bd8dc7e93f9a3f0c
title
Virologic suppression, defined ...... copies/mL Measured at Week 48
@en
type
label
Virologic suppression, defined ...... 4aa1ff48639f4bd8dc7e93f9a3f0c]
@en